| 1 | [SID103628926] | Active | IC50 | 0.4 | Inhibition of CDK4 by radioactive glutathione plate-binding assay [AID348894, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Active | | IC50 | 0.4 [uM] | | BioAssay | Inhibition of CDK4 by radioactive glutathione plate-binding assay | | AID | 348894 | | BioAssay type | Literature | | Target | | | PubMed | 18835709 | | Data Table |  |
|
| 2 | [SID124350069] | Active | Potency | 4.6061 | qHTS Assay for Inhibitors of Firefly Luciferase from the GSK Published Protein Kinase Inhibitor Set [AID652016, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 124350069 | | CID | 10193464 | | Outcome | Active | | Potency | 4.6061 [uM] | | BioAssay | qHTS Assay for Inhibitors of Firefly Luciferase from the GSK Published Protein Kinase Inhibitor Set | | AID | 652016 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 3 | [SID103628926] | Active | IC50 | 25 | Inhibition of GSK3-beta by scintillation proximity assay [AID348896, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Active | | IC50 | 25 [uM] | | BioAssay | Inhibition of GSK3-beta by scintillation proximity assay | | AID | 348896 | | BioAssay type | Literature | | Target | | | PubMed | 18835709 | | Data Table |  |
|
| 4 | [SID103628926] | Unspecified | | | Dose normalized AUC in orally dosed mouse [AID348901, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | Dose normalized AUC in orally dosed mouse | | AID | 348901 | | BioAssay type | Literature | | Target | | | PubMed | 18835709 | | Data Table |  |
|
| 5 | [SID103628926] | Unspecified | | | GSK_PKIS: PIP5K1 (Caliper assay) % inhibition at 5 uM [UNC Frye lab] [AID651545, Type: other] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: PIP5K1 (Caliper assay) % inhibition at 5 uM [UNC Frye lab] | | AID | 651545 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (E255K mutant) mean inhibition at 0.1 uM [Nanosyn] [AID651370, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (E255K mutant) mean inhibition at 0.1 uM [Nanosyn] | | AID | 651370 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 7 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (E255K mutant) mean inhibition at 0.1 uM [Nanosyn] [AID651370, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (E255K mutant) mean inhibition at 0.1 uM [Nanosyn] | | AID | 651370 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 8 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (E255K mutant) mean inhibition at 1 uM [Nanosyn] [AID651371, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (E255K mutant) mean inhibition at 1 uM [Nanosyn] | | AID | 651371 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 9 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (E255K mutant) mean inhibition at 1 uM [Nanosyn] [AID651371, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (E255K mutant) mean inhibition at 1 uM [Nanosyn] | | AID | 651371 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 10 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (H396P mutant) mean inhibition at 0.1 uM [Nanosyn] [AID651372, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (H396P mutant) mean inhibition at 0.1 uM [Nanosyn] | | AID | 651372 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 11 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (H396P mutant) mean inhibition at 0.1 uM [Nanosyn] [AID651372, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (H396P mutant) mean inhibition at 0.1 uM [Nanosyn] | | AID | 651372 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 12 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (H396P mutant) mean inhibition at 1 uM [Nanosyn] [AID651373, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (H396P mutant) mean inhibition at 1 uM [Nanosyn] | | AID | 651373 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 13 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (H396P mutant) mean inhibition at 1 uM [Nanosyn] [AID651373, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (H396P mutant) mean inhibition at 1 uM [Nanosyn] | | AID | 651373 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 14 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (M351T mutant) mean inhibition at 0.1 uM [Nanosyn] [AID651374, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (M351T mutant) mean inhibition at 0.1 uM [Nanosyn] | | AID | 651374 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 15 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (M351T mutant) mean inhibition at 0.1 uM [Nanosyn] [AID651374, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (M351T mutant) mean inhibition at 0.1 uM [Nanosyn] | | AID | 651374 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 16 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (M351T mutant) mean inhibition at 1 uM [Nanosyn] [AID651375, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (M351T mutant) mean inhibition at 1 uM [Nanosyn] | | AID | 651375 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 17 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (M351T mutant) mean inhibition at 1 uM [Nanosyn] [AID651375, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (M351T mutant) mean inhibition at 1 uM [Nanosyn] | | AID | 651375 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 18 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (Q252H mutant) mean inhibition at 0.1 uM [Nanosyn] [AID651376, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (Q252H mutant) mean inhibition at 0.1 uM [Nanosyn] | | AID | 651376 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 19 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (Q252H mutant) mean inhibition at 0.1 uM [Nanosyn] [AID651376, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (Q252H mutant) mean inhibition at 0.1 uM [Nanosyn] | | AID | 651376 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 20 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (Q252H mutant) mean inhibition at 1 uM [Nanosyn] [AID651377, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (Q252H mutant) mean inhibition at 1 uM [Nanosyn] | | AID | 651377 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 21 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (Q252H mutant) mean inhibition at 1 uM [Nanosyn] [AID651377, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (Q252H mutant) mean inhibition at 1 uM [Nanosyn] | | AID | 651377 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 22 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (T315I mutant) mean inhibition at 0.1 uM [Nanosyn] [AID651378, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (T315I mutant) mean inhibition at 0.1 uM [Nanosyn] | | AID | 651378 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 23 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (T315I mutant) mean inhibition at 0.1 uM [Nanosyn] [AID651378, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (T315I mutant) mean inhibition at 0.1 uM [Nanosyn] | | AID | 651378 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 24 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (T315I mutant) mean inhibition at 1 uM [Nanosyn] [AID651379, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (T315I mutant) mean inhibition at 1 uM [Nanosyn] | | AID | 651379 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 25 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (T315I mutant) mean inhibition at 1 uM [Nanosyn] [AID651379, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (T315I mutant) mean inhibition at 1 uM [Nanosyn] | | AID | 651379 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 26 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (Y253F mutant) mean inhibition at 0.1 uM [Nanosyn] [AID651380, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (Y253F mutant) mean inhibition at 0.1 uM [Nanosyn] | | AID | 651380 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 27 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (Y253F mutant) mean inhibition at 0.1 uM [Nanosyn] [AID651380, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (Y253F mutant) mean inhibition at 0.1 uM [Nanosyn] | | AID | 651380 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 28 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (Y253F mutant) mean inhibition at 1 uM [Nanosyn] [AID651381, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (Y253F mutant) mean inhibition at 1 uM [Nanosyn] | | AID | 651381 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 29 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 (Y253F mutant) mean inhibition at 1 uM [Nanosyn] [AID651381, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 (Y253F mutant) mean inhibition at 1 uM [Nanosyn] | | AID | 651381 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 30 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 mean inhibition at 0.1 uM [Nanosyn] [AID651382, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 mean inhibition at 0.1 uM [Nanosyn] | | AID | 651382 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 31 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 mean inhibition at 0.1 uM [Nanosyn] [AID651382, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 mean inhibition at 0.1 uM [Nanosyn] | | AID | 651382 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 32 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 mean inhibition at 1 uM [Nanosyn] [AID651383, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 mean inhibition at 1 uM [Nanosyn] | | AID | 651383 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 33 | [SID103628926] | Unspecified | | | GSK_PKIS: ABL1 mean inhibition at 1 uM [Nanosyn] [AID651383, Type: other] | Tyrosine-protein kinase ABL1 [gi:85681908] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ABL1 mean inhibition at 1 uM [Nanosyn] | | AID | 651383 | | BioAssay type | other | | Target | Tyrosine-protein kinase ABL1 [gi:85681908] | | PubMed | | | Data Table |  |
|
| 34 | [SID103628926] | Unspecified | | | GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn] [AID651386, Type: other] | Abelson tyrosine-protein kinase 2 [gi:1168268] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn] | | AID | 651386 | | BioAssay type | other | | Target | Abelson tyrosine-protein kinase 2 [gi:1168268] | | PubMed | | | Data Table |  |
|
| 35 | [SID103628926] | Unspecified | | | GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn] [AID651386, Type: other] | Abelson tyrosine-protein kinase 2 [gi:1168268] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn] | | AID | 651386 | | BioAssay type | other | | Target | Abelson tyrosine-protein kinase 2 [gi:1168268] | | PubMed | | | Data Table |  |
|
| 36 | [SID103628926] | Unspecified | | | GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn] [AID651387, Type: other] | Abelson tyrosine-protein kinase 2 [gi:1168268] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn] | | AID | 651387 | | BioAssay type | other | | Target | Abelson tyrosine-protein kinase 2 [gi:1168268] | | PubMed | | | Data Table |  |
|
| 37 | [SID103628926] | Unspecified | | | GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn] [AID651387, Type: other] | Abelson tyrosine-protein kinase 2 [gi:1168268] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn] | | AID | 651387 | | BioAssay type | other | | Target | Abelson tyrosine-protein kinase 2 [gi:1168268] | | PubMed | | | Data Table |  |
|
| 38 | [SID103628926] | Unspecified | | | GSK_PKIS: AKT1 mean inhibition at 0.1 uM [Nanosyn] [AID651018, Type: other] | RAC-alpha serine/threonine-protein kinase [gi:60391226] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: AKT1 mean inhibition at 0.1 uM [Nanosyn] | | AID | 651018 | | BioAssay type | other | | Target | RAC-alpha serine/threonine-protein kinase [gi:60391226] | | PubMed | | | Data Table |  |
|
| 39 | [SID103628926] | Unspecified | | | GSK_PKIS: AKT1 mean inhibition at 0.1 uM [Nanosyn] [AID651018, Type: other] | RAC-alpha serine/threonine-protein kinase [gi:60391226] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: AKT1 mean inhibition at 0.1 uM [Nanosyn] | | AID | 651018 | | BioAssay type | other | | Target | RAC-alpha serine/threonine-protein kinase [gi:60391226] | | PubMed | | | Data Table |  |
|
| 40 | [SID103628926] | Unspecified | | | GSK_PKIS: AKT1 mean inhibition at 0.1 uM [Nanosyn] [AID651018, Type: other] | RAC-alpha serine/threonine-protein kinase [gi:60391226] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: AKT1 mean inhibition at 0.1 uM [Nanosyn] | | AID | 651018 | | BioAssay type | other | | Target | RAC-alpha serine/threonine-protein kinase [gi:60391226] | | PubMed | | | Data Table |  |
|
| 41 | [SID103628926] | Unspecified | | | GSK_PKIS: AKT1 mean inhibition at 1 uM [Nanosyn] [AID651019, Type: other] | RAC-alpha serine/threonine-protein kinase [gi:60391226] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: AKT1 mean inhibition at 1 uM [Nanosyn] | | AID | 651019 | | BioAssay type | other | | Target | RAC-alpha serine/threonine-protein kinase [gi:60391226] | | PubMed | | | Data Table |  |
|
| 42 | [SID103628926] | Unspecified | | | GSK_PKIS: AKT1 mean inhibition at 1 uM [Nanosyn] [AID651019, Type: other] | RAC-alpha serine/threonine-protein kinase [gi:60391226] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: AKT1 mean inhibition at 1 uM [Nanosyn] | | AID | 651019 | | BioAssay type | other | | Target | RAC-alpha serine/threonine-protein kinase [gi:60391226] | | PubMed | | | Data Table |  |
|
| 43 | [SID103628926] | Unspecified | | | GSK_PKIS: AKT1 mean inhibition at 1 uM [Nanosyn] [AID651019, Type: other] | RAC-alpha serine/threonine-protein kinase [gi:60391226] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: AKT1 mean inhibition at 1 uM [Nanosyn] | | AID | 651019 | | BioAssay type | other | | Target | RAC-alpha serine/threonine-protein kinase [gi:60391226] | | PubMed | | | Data Table |  |
|
| 44 | [SID103628926] | Unspecified | | | GSK_PKIS: AKT2 mean inhibition at 0.1 uM [Nanosyn] [AID651020, Type: other] | RAC-beta serine/threonine-protein kinase [gi:1170703] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: AKT2 mean inhibition at 0.1 uM [Nanosyn] | | AID | 651020 | | BioAssay type | other | | Target | RAC-beta serine/threonine-protein kinase [gi:1170703] | | PubMed | | | Data Table |  |
|
| 45 | [SID103628926] | Unspecified | | | GSK_PKIS: AKT2 mean inhibition at 0.1 uM [Nanosyn] [AID651020, Type: other] | RAC-beta serine/threonine-protein kinase [gi:1170703] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: AKT2 mean inhibition at 0.1 uM [Nanosyn] | | AID | 651020 | | BioAssay type | other | | Target | RAC-beta serine/threonine-protein kinase [gi:1170703] | | PubMed | | | Data Table |  |
|
| 46 | [SID103628926] | Unspecified | | | GSK_PKIS: AKT2 mean inhibition at 0.1 uM [Nanosyn] [AID651020, Type: other] | RAC-beta serine/threonine-protein kinase [gi:1170703] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: AKT2 mean inhibition at 0.1 uM [Nanosyn] | | AID | 651020 | | BioAssay type | other | | Target | RAC-beta serine/threonine-protein kinase [gi:1170703] | | PubMed | | | Data Table |  |
|
| 47 | [SID103628926] | Unspecified | | | GSK_PKIS: AKT2 mean inhibition at 1 uM [Nanosyn] [AID651021, Type: other] | RAC-beta serine/threonine-protein kinase [gi:1170703] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: AKT2 mean inhibition at 1 uM [Nanosyn] | | AID | 651021 | | BioAssay type | other | | Target | RAC-beta serine/threonine-protein kinase [gi:1170703] | | PubMed | | | Data Table |  |
|
| 48 | [SID103628926] | Unspecified | | | GSK_PKIS: AKT2 mean inhibition at 1 uM [Nanosyn] [AID651021, Type: other] | RAC-beta serine/threonine-protein kinase [gi:1170703] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: AKT2 mean inhibition at 1 uM [Nanosyn] | | AID | 651021 | | BioAssay type | other | | Target | RAC-beta serine/threonine-protein kinase [gi:1170703] | | PubMed | | | Data Table |  |
|
| 49 | [SID103628926] | Unspecified | | | GSK_PKIS: AKT2 mean inhibition at 1 uM [Nanosyn] [AID651021, Type: other] | RAC-beta serine/threonine-protein kinase [gi:1170703] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: AKT2 mean inhibition at 1 uM [Nanosyn] | | AID | 651021 | | BioAssay type | other | | Target | RAC-beta serine/threonine-protein kinase [gi:1170703] | | PubMed | | | Data Table |  |
|
| 50 | [SID103628926] | Unspecified | | | GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn] [AID651384, Type: other] | ALK tyrosine kinase receptor [gi:296439447] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103628926 | | CID | 10193464 | | Outcome | Unspecified | | BioAssay | GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn] | | AID | 651384 | | BioAssay type | other | | Target | ALK tyrosine kinase receptor [gi:296439447] | | PubMed | | | Data Table |  |
|